Josh Gottheimer sold Neurocrine Biosciences Inc (NASDAQ: NBIX)
Josh Gottheimer (D-NJ), a U.S. Representative, has disclosed 1 trade in Neurocrine Biosciences Inc (NBIX) since 2018, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Josh Gottheimer sold $1,001 - $15,000 of Neurocrine Biosciences Inc (NASDAQ: NBIX) on December 13, 2018. Since that trade, NBIX is up +147.62% against the S&P 500 up +208.29%, an outperformance of -60.66%.
Data updated
Josh Gottheimer's NBIX trades vs the price
NBIX is up +147.62% since Josh Gottheimer sold on December 13, 2018, versus +208.29% for the S&P 500.
Performance since this trade
All Josh Gottheimer NBIX trades
Josh Gottheimer & NBIX trading FAQ
Is it legal for Josh Gottheimer to trade Neurocrine Biosciences Inc (NBIX) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Neurocrine Biosciences Inc (NBIX), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Josh Gottheimer sell NBIX?
Josh Gottheimer disclosed a sale of $1,001 - $15,000 of Neurocrine Biosciences Inc (NBIX) on December 13, 2018, according to public STOCK Act filings.
How has NBIX performed since Josh Gottheimer's trade?
Since Josh Gottheimer sold NBIX on December 13, 2018, the stock is up +147.62%, versus +208.29% for the S&P 500 over the same period, an outperformance of -60.66%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NBIX trades?
Quantellect tracks every disclosed congressional trade in Neurocrine Biosciences Inc (NBIX) on the Neurocrine Biosciences Inc congressional trading page, which aggregates filings across all members of Congress.
Josh Gottheimer's NBIX tradesAll congressional filings for Neurocrine Biosciences IncJosh Gottheimer's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.